************************ ************************

Qualifying Conditions for Medical Cannabis in Texas

Cannabis medicine is available for Texans diagnosed with specific medical conditions. More than 200 physicians in Texas are registered to prescribe cannabis to eligible patients.

 

At Texas Original Compassionate Cultivation, we work with patients and their physicians in the journey towards healing and relief.

 

We produce all of our cannabis products from seed-to-solution, focusing on consistency and quality in every batch.
1 +
Current Qualifying Conditions
2 Million
Texans Are Eligible

Cannabis in Texas?

Passed into law in 2015 and expanded in 2019, the Texas Compassionate Use Program allows cannabis to be used as a practical medical treatment for patients suffering from specific medical conditions. To learn more about the history and current state of marijuana legality in Texas, see our Guide to the Texas Compassionate Use Act. LEARN MORE>

What Conditions Are Approved for Medical Cannabis in Texas?

ALS

(Amyotrophic Lateral Sclerosis)

Alzheimer’s Disease

and other dementias

Autism

and other spectrum disorders

CTE

(Chronic Traumatic Encephalopathy)

Epilepsy

and other seizure disorders

MS

(Multiple Sclerosis)

Parkinson’s Disease

Spasticity

Terminal Cancer

  • 3-hydroxy-3-methylglutaryl-CoA lyase deficiency
  • 5-aminoimidazole-4-carboxamide ribonucleotide transformylase deficiency

 

A

  • Adenylosuccinate synthase Deficiency
  • Alexander disease
  • Alpers-Huttenlocher syndrome
  • Alpha-fucosidosis
  • Alzheimer’s Disease
  • Amyloidoses
  • Amyotrophic lateral sclerosis
  • Argyrophilic Grain Disease
  • Aromatic L-amino acid decarboxylase deficiency
  • Asparylglucosaminuria
  • Ataxia neuropathy spectrum

 

B

  • Bidirectional enzyme deficiency
  • Biopterin Defects

 

C

  • Canavan disease
  • Central Core
  • Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy
  • Charcot Marie Tooth and related hereditary neuropathies
  • Childhood Myocerebrohepatopathy spectrum
  • Chronic Traumatic Encephalopathy
  • Congenital Disorders of Glycosylation
  • Corticobasal Degeneration
  • Creatine Disorders
  • Creatine Transporter Defect, also known as SLC 6A8
  • Creutzfeldt-Jakob Disease

 

D

  • Dementia with Lewy Bodies
  • Deoxyguanisine kinase deficiency
  • Dihydropirimidinase Deficiency
  • Dihydropteridine reductase
  • Dihydropyrimidine dehydrogenase Deficiency
  • Duchenne Muscular Dystrophy

 

F

  • Facioscapulohumeral Muscular Dystrophy
  • Familial or Sporadic Fatal Insomnia
  • Familial Spastic Paraplegia
  • Farber Disease
  • Fatty Acid Oxidation
  • Freidreich’s Ataxia
  • Frontotemporal dementia and parkinsonism linked to chromosome 17 caused by mutations in MAPT gene
  • Frontotemporal Lobar Degeneration

 

G

  • Galactosemia
  • Galactosialidosis
  • Gaucher Type 2 and Type 3
  • Gerstmann-Straussler-Scheinker Disease
  • Globular Glial Tauopathy
  • Glutaric acidemia type 1
  • Glycine encephalopathy, also known as non-ketotic hyperglycinemia
  • Glycogen Storage-Lysosomal: Pompe Disease
  • GM1 gangliosidosis
  • GM2 gangliosidosis also known as Tay-sachs and Sandhoff Disease
  • Guanidinoacetate methytransferase deficiency
  • Guanosine triphosphate cyclohydrolase deficiency

 

H

  • Homocysteine re-methylation defects
  • Huntington’s Disease
  • Hypoxanthine-guanine phosophoribosyltransferase Deficiency also known as Lesch-Nyhan disease

 

K

  • Kearn Sayers Syndrome
  • Krabbe
  • Kuru

 

L

  • L-2-hydroxyglutaric aciduria
  • L-Arginine/glycine amidinotransferase deficiency
  • Leukodystrophy
  • Lewy Body Disorders
  • Long-chain L-3 hydroxyacyl-CoA dehydrogenase deficiency
  • Lysosomal Storage Diseases

 

M

  • Mannosidosis
  • Manosidosis alpha and beta
  • Maple Syrup Urine Disease
  • Metachromatic leukodystrophy
  • Metal Metabolism
  • Methylenetetrahydrofolate reductase deficiency severe variant
  • Mitochondrial Conditions
  • Mitochondrial Depletion syndromes types 1 through 14
  • Mitochondrial Encephalopathy Lactic Acidosis Stroke
  • Mitochondrial Encephalopathy Ragged Red Fiber
  • Mitochondrial neurogastrointestinal encephalopathy
  • Monoamine oxidase deficiency
  • Motor Neuron Disease
  • Mucolipidoses
  • Mucolipidoses Type II, also known as Inclusion Cell disease
  • Mucolipidoses Type III, also known as pseudo-Hurler polydystrophy
  • Mucopolysaccaridosis
  • Mucopolysaccharidosis Type I, also known as Hurler Syndrome or Scheie Syndrome
  • Mucopolysaccharidosis Type II, also known as Hunter Syndrome
  • Mucopolysaccharidosis Type III, also known as Sanfilippo A and B
  • Mucopolysaccharidosis Type IV, also known as Maroteaux-Lamy
  • Mucopolysaccharidosis Type VII, also known as Sly
  • Multiple Sulfatase deficiency
  • Multiple System Atrophy
  • Muscular Dystrophies
  • Myoclonic epilepsy myopathy sensory ataxia

 

N

  • Neimann Pick Type A and B
  • Neimann Pick Type C
  • Neonatal Adrenoleukodystrophy
  • Neurodegeneration with brain iron accumulation
  • Neurofibrillary Tangle dementia, also known as Primary Age-related Tauopathy
  • Neuronal ceroid lipofuscinosis types 1-10 including Batten Disease
  • Neuropathy, Ataxia, and Retinitis Pigmentosa
  • Neurotransmitter defects

O

  • Oligosaccharidoses

 

P

  • Pantothenate Kinase Associated Neurodegeneration
  • Parkinson’s Disease
  • Pelizaeus-Merzbacher disease
  • Peripheral neuropathy types 1 through 4
  • Peroxisomal biosynthesis defects
  • Peroxisomal Disorders
  • Pick Disease
  • Polymerase G Related Disorders
  • Polyol disorders
  • Primary Lateral Sclerosis
  • Prion Diseases
  • Progressive Choreas
  • Progressive dystonias DYT genes 1 through 20
  • Progressive Muscular Atrophy
  • Progressive Supranuclear Palsy
  • Pterin-4-carbinolamine dehydratase
  • Purine and Pyrimidine Defects
  • Pyruvate Carboxylase Deficiency
  • Pyruvate Dehydrogenase Deficiency
  • Pyruvoyl-tetahydropterin synthase

 

R

  • Refsum Disease
  • Respiratory chain disorders complex 1 through 4 defects: Co Q biosynthesis defects
  • RRM2B-related mitochondrial disease

 

S

  • Salidosis
  • Schindler
  • Segawa Diease, also known as Dopamine Responsive Dystonia
  • Sepiapterin reductase
  • Sialidosis
  • Sphingolipidoses
  • Spinal-bulbar muscular atrophy
  • Spinal Muscular Atrophy
  • Spinocerebellar ataxia
  • Subacute necrotizing encephalopathy, also known as Leigh syndrome
  • SUCLG1-related mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria
  • Synucleinopathies

 

T

  • Tauopathies
  • Thymidine Kinase
  • Transactive response DNA-binding protein-43 (TDP-43) Proteinopathies
  • Trifunctional protein deficiency

 

V

  • Vascular dementia

 

W

  • Wilson Disease

 

X

  • X-linked adrenoleukodystrophy

 

Z

  • Zellweger syndrome
Across the state, cannabis is having profound effects in transforming lives for many of our patients and their families.

What Symptoms Can Cannabis Improve?

The cannabis plant contains a wide variety of naturally-occurring chemical compounds called cannabinoids. When formulated to the correct ratios, cannabinoids have shown to provide relief for a variety of unwanted symptoms.

 

We produce our medicine in two primary formulations (High-CBD & Balanced), with the focused goal of treating the most commonly experienced symptoms of a patient’s condition.

 

Clinical trials report positive effects on the below symptoms, listed by recommended formulation.

How Do I Obtain A Medical Cannabis Prescription?

Do you or a loved one qualify for medical cannabis?

 

Whether you need assistance with finding a doctor or facilitating a conversation with your current doctor, let us help.
Why Do I Need a Prescription?

Different from unregulated over-the-counter CBD products, Compassionate Cultivation cannabis products are carefully regulated by the Texas Department of Public Safety to achieve the highest standards of quality, purity, and consistency. In addition, medical cannabis products in Texas contain up to 0.5% tetrahydrocannabinol by weight – 67% more than retail or hemp-based products. Clinical research suggests inclusion of tetrahydrocannabinol can contribute to better medical results. It should be taken under the care and guidance of a registered physician.

What If My Condition Isn’t Listed?

We believe in increasing access to all who can benefit from this powerful plant. If you don’t see your condition at this time, laws can change, and we will send notifications via email and our our social channels as soon as they do. If you know someone with a condition that can be treated, please help them by sharing this page!
FIND A DOCTOR